Partners Capital Investment Group »

Urogen Pharma shares owned by Partners Capital Investment Group

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Partners Capital Investment Group from 13F filings

Historical chart of Partners Capital Investment Group investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Partners Capital Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Partners Capital Investment Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $195k 15k 12.70
2024-06-30 $258k 15k 16.78
2023-12-31 $231k 15k 15.00
2023-09-30 $216k 15k 14.01
2023-06-30 $159k 15k 10.35

More positions owned by Partners Capital Investment Group

iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
Vanguard S&P 500 ETF S&p 500 Etf Shs (VOO)
iShares MSCI Emerging Markets ex China ETF Etf - Equity (EMXC)
SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Bloomberg 1-3 Month T-bill Etf (BIL)
Vanguard Total World Stock ETF Tt Wrld St Etf (VT)
iShares 0-3 Month Treasury Bond ETF 0-3 Mnth Treasry (SGOV)
Vanguard Short-Term Treasury ETF Short Term Treas (VGSH)
Vanguard Value ETF Value Etf (VTV)
iShares Core MSCI Emerging Markets ETF Core Msci Emkt (IEMG)
Vanguard Mun Bd Fd In mutual (VWSUX)
iShares Currency Hedged MSCI EAFE ETF Hdg Msci Eafe (HEFA)
Xtrackers MSCI Japan Hedged Equity ETF Xtrack Msci Japn (DBJP)
iShares Trust iShares ESG Aware MSCI USA ETF Esg Awr Msci Usa (ESGU)
SPDR S&P 500 ETF Trust Tr Unit (SPY)
iShares 0-5 Year TIPS Bond ETF 0-5 Yr Tips Etf (STIP)

View all positions for Partners Capital Investment Group

Top funds holding Urogen Pharma

Rtw Investments
Adage Capital Partners GP
BlackRock
Menora Mivtachim Holdings
Toronto-Dominion Bank
Ubs Global Asset Management Americas
Nantahala Capital Management
Leucadia National Corporation
UBS Group
Silverarc Capital Management
Rosalind Advisors
State Street Corporation
Morgan Stanley
Migdal Insurance & Financial Holdings
Millennium Management

View all funds holding Urogen Pharma